Ingenus Pharmaceuticals
Dr. Billa has a PhD in Pharmaceutics with over 20 years of proven experience in pre-formulations, analytical R&D, formulation development, bio-studies, and regulatory submissions. He held key positions in pharmaceutical R & D at Wockhardt, Reddy’s Laboratories and Orchid Pharma, Ltd. Dr. Billa was instrumental in developing over 100 ANDA’s and managed over 20 Paragraph IV challenges. He has developed several complex dosage forms, modified release tablets and capsules, suspensions and lyophilized injectables, and has developed over 30 Injectable ANDA products, which involved PENAMS and Cephalosporins. Dr. Billa has significant experience in solid oral dosages (IR and MR), topicals, liquids, and parenterals, and holds has several patents (U.S. and WO) and publications.
This person is not in any offices
Ingenus Pharmaceuticals
1 followers
Ingenus Pharmaceuticals is an emerging privately held U.S. based generic pharmaceutical company with manufacturing and research and development facilities in the U.S.,Switzerland, and India. Since 2010, Ingenus has been developing, manufacturing and commercializing quality generic medications as cost effective solutions for patients and suppliers. With over 65 filings covering a wide range of therapeutic classes ,including transdermal, parenteral, semi-solids, injectable, and extended release products Ingenus is well positioned to becoming a leader in the generic pharmaceutical industry.